The Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis
Report Keywords – China Biopharmaceutical, Contract Manufacturing, Manufacturing Market, RootsAnalysis, Report The growing biopharma industry in China has resulted in the creation of lucrative business opportunities for contract service providers;…
